benzyloxycarbonylleucyl-leucyl-leucine aldehyde

glycogen synthase kinase 3 beta ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30868765 A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. 2019 May 1
2 29968965 Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer. 2018 Aug 1
3 30191639 Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells. 2018 Nov 1
4 28196122 Detrimental ELAVL-1/HuR-dependent GSK3β mRNA stabilization impairs resolution in acute respiratory distress syndrome. 2017 1
5 25941117 Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3β dependent mechanism. 2015 May 5 2
6 26087957 MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine. 2015 Jul 1
7 24752588 Proteasome inhibition-induced downregulation of Akt/GSK-3β pathway contributes to abnormality of tau in hippocampal slice. 2014 Dec 1
8 23325562 Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells. 2013 Nov 1
9 23357875 Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines. 2013 1
10 23524145 Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib. 2013 Jun 10 1
11 22310719 Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. 2012 Feb 24 1
12 22791147 Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. 2012 1
13 19765735 MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype. 2010 Jan 1